Cargando…

Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world

OBJECTIVES: The hepatitis B vaccine comprises hepatitis B surface antigen (HBsAg) produced by transgenic yeast cells. There are few serious adverse events (SAE) reports after Hepatitis B vaccination. METHODS: The authors searched the Chinese legal documents database for all SAE with Hepatitis B vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jinmiao, Zhang, Xunjie, Xu, Hong, Li, Zhiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538941/ https://www.ncbi.nlm.nih.gov/pubmed/36210931 http://dx.doi.org/10.3389/fped.2022.888686

Ejemplares similares

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
por: Lu, Jinmiao, et al.
Publicado: (2022)

Impact of mRNA-based vaccines in the prevention of adverse outcomes of COVID-19 infection in pregnancy: a single-center cohort study
por: Tudisco, Riccardo, et al.
Publicado: (2023)

Case report: Five patients with myocarditis after mRNA COVID-19 vaccination
por: Murase, Hiroki, et al.
Publicado: (2022)

COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?
por: Maleki, Arash, et al.
Publicado: (2021)

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
por: Fraiman, Joseph, et al.
Publicado: (2022)

Case report: Myocarditis with nonsustained ventricular tachycardia following COVID-19 mRNA vaccination in a female adolescent
por: Han, Jeongho, et al.
Publicado: (2022)

A potentially serious adverse effect of GLP-1 receptor agonists
por: Lu, Jinmiao, et al.
Publicado: (2023)

Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan
por: Kitagawa, Hiroki, et al.
Publicado: (2022)

Estimation of Real-World Vaccination Effectiveness of mRNA COVID-19 Vaccines against Delta and Omicron Variants in Japan
por: Kodera, Sachiko, et al.
Publicado: (2022)

COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says
por: Chen, Gang, et al.
Publicado: (2021)

Uveitis following mRNA COVID-19 vaccination: Is it real?
por: Murugan, Sivaraman Bala, et al.
Publicado: (2023)

Real-World Effectiveness of the mRNA COVID-19 Vaccines in Japan: A Case–Control Study
por: Hara, Megumi, et al.
Publicado: (2022)

Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis
por: Xu, Wanqian, et al.
Publicado: (2023)

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
por: Trougakos, Ioannis P., et al.
Publicado: (2022)

Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
Publicado: (2021)

The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data
por: Sa, Soonok, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Factors related to the serious adverse events in patients visiting the emergency department after ChAdOx1 and mRNA COVID-19 vaccination
por: Jeong, Won Jung, et al.
Publicado: (2022)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

Effects of bronchoalveolar lavage on Mycoplasma Pneumoniae pneumonia: A propensity score matched-cohort study
por: Lu, Jinmiao, et al.
Publicado: (2023)

A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan
por: Takeuchi, Yoshinori, et al.
Publicado: (2022)

No adverse effects found for prenatal exposure to mRNA COVID-19 vaccine
Publicado: (2022)

COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns
por: Trougakos, Ioannis P., et al.
Publicado: (2022)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
por: Giannotta, Girolamo, et al.
Publicado: (2023)

Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies
por: Kow, Chia Siang, et al.
Publicado: (2021)

Real-life vaccination coverage in Slovak children with rheumatic diseases
por: Balažiová, Barbora, et al.
Publicado: (2022)

Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS
por: Yan, Ming-Ming, et al.
Publicado: (2022)

Microarray analysis of lncRNA and mRNA expression profiles in patients with Legg-Calve-Perthes disease
por: Wang, Shangyu, et al.
Publicado: (2022)

572. Real-world Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in a Retrospective Cohort
por: Vahidy, Farhaan S, et al.
Publicado: (2021)

Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review
por: Palalay, Harvey, et al.
Publicado: (2023)

Serious adverse events associated with yellow fever vaccine
por: de Menezes Martins, Reinaldo, et al.
Publicado: (2015)

Adverse Reaction to COVID-19 mRNA Vaccination in a Patient With VEXAS Syndrome
por: Ciprian, Giulio
Publicado: (2022)

Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020)

Variant constraint by mRNA vaccines
por: Bordon, Yvonne
Publicado: (2021)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6joggrjqt5ikqethqis25sihqf